2022
DOI: 10.3892/etm.2022.11161
|View full text |Cite
|
Sign up to set email alerts
|

Long non‑coding RNA TUG1 sponges microRNA‑9 to protect podocytes from high glucose‑induced apoptosis and mitochondrial dysfunction via SIRT1 upregulation

Abstract: Podocyte apoptosis and mitochondrial dysfunction serve a major role in diabetic nephropathy progression. The present study revealed a molecular mechanism regulating podocyte apoptosis and mitochondrial dysfunction. In vitro models were established using conditionally immortalized mouse podocyte clonal cells treated with high glucose (HG). Reverse quantitative-transcription PCR were used to detect gene expression, western blotting and immunofluorescence were used to detect protein expression, Cell Counting Kit-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…LncRNA TUG1 has been involved in various physiological functions, including cell proliferation, migration and death, and regulation of cell cycle (reviewed in Guo et al, 2020 ). In the context of renal damage, TUG1 seems to be involved in podocyte apoptosis and effacement ( Shen et al, 2019 ; Lei et al , 2022 ), which are involved in glomerular dysfunction and proteinuria. This lncRNA was reported as being downregulated in podocytes of T2DM db/db mice compared to control animals and also in the glomeruli of DKD patients ( Long et al, 2016 ).…”
Section: Discussionmentioning
confidence: 99%
“…LncRNA TUG1 has been involved in various physiological functions, including cell proliferation, migration and death, and regulation of cell cycle (reviewed in Guo et al, 2020 ). In the context of renal damage, TUG1 seems to be involved in podocyte apoptosis and effacement ( Shen et al, 2019 ; Lei et al , 2022 ), which are involved in glomerular dysfunction and proteinuria. This lncRNA was reported as being downregulated in podocytes of T2DM db/db mice compared to control animals and also in the glomeruli of DKD patients ( Long et al, 2016 ).…”
Section: Discussionmentioning
confidence: 99%
“…140 saponin derived from Astragalus membranaceus, which inhibits the expression of TRAF5 and reduces podocyte apoptosis through the upregulation of TUG1. 144 In conclusion, more research is required to fully understand the therapeutic potential of lncRNAs in DKD.…”
Section: Lncrnas Applied In Dkd Treatmentmentioning
confidence: 99%
“…In addition, Danggui buxue tang dose‐dependently upregulated the expression of GAS5 in MMCs and inhibited the expression of LN, FN, and col IV by regulating the expression of inhibitor of κB kinase (IKK) and the activity of NF‐κB through GAS5, which, in turn, prevented the effects of DKD by inhibiting the cell proliferation and ECM accumulation in MCs 143 . The therapeutic action of DKD is achieved by Astragaloside IV (AS‐IV), a saponin derived from Astragalus membranaceus, which inhibits the expression of TRAF5 and reduces podocyte apoptosis through the upregulation of TUG1 144 . In conclusion, more research is required to fully understand the therapeutic potential of lncRNAs in DKD.…”
Section: Dkd‐related Lncrnas In Clinical Applicationmentioning
confidence: 99%
“…Another work also demonstrated that lncRNA TUG1 reduced accumulation of extracellular matrix by sponging miR-377 and targeting PPARγ in diabetic nephropathy ( 66 ). Moreover, lncRNA TUG1 interacted with miR-9 and upregulated SIRT1, resulting in protection of podocytes from high glucose-triggered apoptosis and mitochondrial dysfunction ( 67 ). Urinary lncRNA TUG1 was positively associated with miR-29a, miR-93 and eGFR in type 2 DM, while lncRNA TUG1 had a negative association with miR-21, miR-124, podocalyxin, NAG and synaptopodin ( 38 ).…”
Section: Role Of Lncrnas In Dkdmentioning
confidence: 99%